Slipped capital femoral epiphysis
(Redirected from Slipped epiphysis)
Slipped Capital Femoral Epiphysis | |
---|---|
Slipped capital femoral epiphysis.jpg | |
Synonyms | N/A |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Hip pain, knee pain, limping |
Complications | Avascular necrosis, osteoarthritis |
Onset | Adolescence |
Duration | |
Types | N/A |
Causes | Unknown, risk factors include obesity, hormonal changes |
Risks | Obesity, endocrine disorders |
Diagnosis | X-ray, MRI |
Differential diagnosis | N/A |
Prevention | N/A |
Treatment | Surgery, physical therapy |
Medication | N/A |
Prognosis | Good with early treatment |
Frequency | 10.8 per 100,000 children |
Deaths | N/A |
Slipped Capital Femoral Epiphysis (SCFE) is a medical condition affecting the hip joint in adolescents. It occurs when the femoral head slips off the femoral neck through the growth plate (physis). This condition is considered an orthopedic emergency due to the risk of avascular necrosis and long-term osteoarthritis.
Epidemiology[edit | edit source]
SCFE is the most common hip disorder in adolescents, with an incidence of approximately 10.8 per 100,000 children. It typically occurs during the adolescent growth spurt, between the ages of 10 and 16 years. The condition is more prevalent in males than females and is more common in African American and Hispanic populations.
Etiology[edit | edit source]
The exact cause of SCFE is unknown, but several risk factors have been identified:
- Obesity: Increased body weight places additional stress on the growth plate.
- Endocrine disorders: Conditions such as hypothyroidism, growth hormone deficiency, and hypogonadism are associated with SCFE.
- Genetic factors: There may be a hereditary component, as SCFE can occur in families.
Pathophysiology[edit | edit source]
In SCFE, the epiphyseal plate (growth plate) becomes weakened, allowing the femoral head to slip posteriorly and inferiorly relative to the femoral neck. This slippage disrupts the normal alignment of the hip joint and can lead to impaired blood supply to the femoral head, increasing the risk of avascular necrosis.
Clinical Presentation[edit | edit source]
Patients with SCFE typically present with:
- Hip pain: Often referred to the knee, leading to diagnostic confusion.
- Limping: Due to pain and mechanical instability of the hip.
- Limited range of motion: Particularly in internal rotation and abduction.
Diagnosis[edit | edit source]
The diagnosis of SCFE is primarily made through imaging studies:
- X-ray: The primary diagnostic tool, showing displacement of the femoral head relative to the femoral neck.
- MRI: Useful in early or atypical cases to assess the growth plate and surrounding structures.
Classification[edit | edit source]
SCFE is classified based on the degree of slippage:
- Stable SCFE: The patient can walk with or without crutches.
- Unstable SCFE: The patient cannot walk, even with crutches, and is at higher risk for complications.
Treatment[edit | edit source]
The primary treatment for SCFE is surgical intervention:
- In situ pinning: The most common procedure, involving the insertion of a single screw to stabilize the femoral head.
- Open reduction and internal fixation: Used in severe cases to realign the femoral head.
Post-surgical management includes physical therapy to restore hip function and prevent complications.
Prognosis[edit | edit source]
With early diagnosis and appropriate treatment, the prognosis for SCFE is generally good. However, delayed treatment can lead to complications such as avascular necrosis and osteoarthritis, which may require further surgical intervention.
Complications[edit | edit source]
- Avascular necrosis: Loss of blood supply to the femoral head, leading to bone death.
- Chondrolysis: Rapid loss of articular cartilage, resulting in joint stiffness and pain.
- Osteoarthritis: Degenerative joint disease due to abnormal joint mechanics.
Prevention[edit | edit source]
While SCFE cannot be entirely prevented, early recognition and management of risk factors such as obesity and endocrine disorders can reduce the likelihood of occurrence.
See also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD